Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)

3.55
Delayed Data
As of 4:00pm ET
 +0.04 / +1.14%
Today’s Change
1.20
Today|||52-Week Range
4.54
+129.03%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Anzalone Christopher Richard
Chief Executive Officer
Sale12/13/2016300,444$1.27$381.6K+176.38%
Given Bruce D
Chief Operating Officer
Gift1/01/2017380,000$0.00$0.00+108.93%
Myszkowski Kenneth Allen
Chief Financial Officer
Gift1/01/2017145,000$0.00$0.00+108.93%
Obrien Patrick /arrowhead/
General Counsel
Gift1/01/2017145,000$0.00$0.00+108.93%
Leone Peter B
Gift1/01/201790,000$0.00$0.00+108.93%
Given Douglass B
Director
Gift1/01/201780,000$0.00$0.00+108.93%
Perry Michael S
Director
Gift1/01/201780,000$0.00$0.00+108.93%
Frykman Edward W
Director
Gift1/01/201750,000$0.00$0.00+108.93%
Ferrari Mauro
Director
Gift1/01/201750,000$0.00$0.00+108.93%
Anzalone Christopher Richard
Chief Executive Officer
Gift4/12/2017978,000$0.00$0.00+112.73%
Page of 2